by Gospa News Editorial Staff
The court of the Belgian city of Liege will hold a session to consider whether President of the European Commission (EC) Ursula von der Leyen has legal immunity against charges on corruption when procuring COVID-19 vaccines to the amount over 35 bln euro, Frederic Baldan, the plaintiff, told TASS.
“The court hearing on January 6 will be held upon an address of the EU office of prosecutor that should investigate acts of corruption in EU institutions but which is de facto acting to defend von der Leyen now. The European Public Prosecutor’s Office sent an address to the court, stating that von der Leyen has the immunity against court prosecution on charges of corruption when buying COVID-19 vaccines that did not pass clinical trials,” Baldan said.
He expressed confidence that the EC President cannot have such immunity because she was “far beyond her authority.”
Von der Leyen is charged with entering into a procurement contract for vaccines with trials not yet completed via SMS correspondence with Pfizer CEO Albert Bourla without prior agreement with EU countries.
Pfizergate: What is EC Chief Von Der Leyen Accused of?
In 2022, US media reported that von der Leyen had communicated with Albert Bourla, chief executive of the US pharmaceutical giant Pfizer, about clinching a long-term contract to purchase 1.8 billion doses of COVID-19 vaccines worth €35 billion ($37.6 billion), even before they passed clinical trials.
Negotiations on the deal were conducted informally in late 2020 via SMS messages and without prior consent of EU member states.
The European Commission President also texted her husband, Heiko von der Leyen, who serves as the medical director at Orgenesis, a company that collaborates with Pfizer. All the messages were then accidentally deleted, Ursula von der Leyen claimed.
The New York Times described the European Commission President’s COVID vaccine deal with the Pfizer CEO as “a striking alignment of political survival and corporate hustle.”
MAIN SOURCE
RELATED TOPICS
Bill Gates to Stand Trial in European Union Country in COVID Vaccine Injury Lawsuit